<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02473419</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 15-0399</org_study_id>
    <nct_id>NCT02473419</nct_id>
  </id_info>
  <brief_title>Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment</brief_title>
  <acronym>VAYA-fMRI</acronym>
  <official_title>Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New York University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Enzymotec</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Medical Research Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this research is to use functional magnetic resonance imaging (fMRI) with a
      neuropsychological task to test the prefrontal mechanism of action of the medical food
      Vayarin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators prior research suggests that effective non-stimulant treatments for ADHD
      act through key prefrontal regions that subserve inhibitory and executive functions, although
      different medications may achieve these effects via distinct mechanisms. The objective of
      this research is to use functional magnetic resonance imaging (fMRI) with a face go/no-go
      task to test the prefrontal mechanism of action of the medical food Vayarin. Participants are
      not treated at the Icahn School of Medicine, but instead will be recruited from trials of
      Vayarin that are enrolling and treating participants at New York University and The Medical
      Research Network.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">March 2, 2017</completion_date>
  <primary_completion_date type="Actual">March 2, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the emotional go/no-go task</measure>
    <time_frame>Baseline and 16 weeks</time_frame>
    <description>Change in the emotional go/no-go task performed in the fMRI scanner at 16 weeks as compared to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the resting state fMRI</measure>
    <time_frame>Baseline and 16 weeks</time_frame>
    <description>Change in the resting state fMRI at 16 weeks as compared to baseline</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">107</enrollment>
  <condition>ADHD</condition>
  <arm_group>
    <arm_group_label>Vayarin</arm_group_label>
    <description>Vayarin x 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <description>Placebo x 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vayarin and Placebo</arm_group_label>
    <description>Placebo x 8 weeks and then Vayarin x 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vayarin</intervention_name>
    <arm_group_label>Vayarin</arm_group_label>
    <arm_group_label>Vayarin and Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Vayarin and Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be subjects participating in a Vayarin clinical trial being conducted at
        NYU and The Medical Research Network in NYC.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects eligible to enroll in the Vayarin clinical study according to screening visit
             will be asked to participate in the fMRI study.

          -  Must be willing and able to perform fMRI scanning

          -  Must maintain compliance to their trials' protocols

        Exclusion Criteria:

          -  pre-existing medical or psychological condition that precludes scanning (e.g.,
             claustrophobia, morbid obesity)

          -  implanted medical device (e.g., pacemaker)

          -  metal in the body that cannot be removed (e.g., braces)

          -  pregnancy

          -  concomitant use of anti-hypertensives or any other medications affecting the blood
             oxygenation level-dependent (BOLD) signal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Newcorn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2015</study_first_submitted>
  <study_first_submitted_qc>June 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2015</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medical food</keyword>
  <keyword>ADHD</keyword>
  <keyword>Vayarin</keyword>
  <keyword>Fish Oil</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

